0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Biological Vaccines Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-33U11404
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Veterinary Biological Vaccines Market Research Report 2022
BUY CHAPTERS

Global Veterinary Biological Vaccines Market Research Report 2025

Code: QYRE-Auto-33U11404
Report
February 2025
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Biological Vaccines Market Size

The global market for Veterinary Biological Vaccines was valued at US$ 5442 million in the year 2024 and is projected to reach a revised size of US$ 8083 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Veterinary Biological Vaccines Market

Veterinary Biological Vaccines Market

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 551%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Biological Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Biological Vaccines.
The Veterinary Biological Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Biological Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Biological Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Biological Vaccines Market Report

Report Metric Details
Report Name Veterinary Biological Vaccines Market
Accounted market size in year US$ 5442 million
Forecasted market size in 2031 US$ 8083 million
CAGR 5.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Livestock
  • Swine
  • Chicken
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Yebio, DHN, WINSUN, Elanco, Virbac, CAVAC, Kyoto Biken Laboratories, FATRO, Vaksindo, Bio-Labs, Avimex Animal Health, MEVAC, Biovac, Atafen, Dyntec, Ringpu Biology, Jinyu Bio-technology, Jinhe Biotechnology, China Animal Husbandry Industry, Wuhan Keqian Biology, Pulike Biological Engineering, Chengdu Kanghua Biological Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Biological Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Biological Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Veterinary Biological Vaccines Market growing?

Ans: The Veterinary Biological Vaccines Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Veterinary Biological Vaccines Market size in 2031?

Ans: The Veterinary Biological Vaccines Market size in 2031 will be US$ 8083 million.

Who are the main players in the Veterinary Biological Vaccines Market report?

Ans: The main players in the Veterinary Biological Vaccines Market are Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Yebio, DHN, WINSUN, Elanco, Virbac, CAVAC, Kyoto Biken Laboratories, FATRO, Vaksindo, Bio-Labs, Avimex Animal Health, MEVAC, Biovac, Atafen, Dyntec, Ringpu Biology, Jinyu Bio-technology, Jinhe Biotechnology, China Animal Husbandry Industry, Wuhan Keqian Biology, Pulike Biological Engineering, Chengdu Kanghua Biological Products

What are the Application segmentation covered in the Veterinary Biological Vaccines Market report?

Ans: The Applications covered in the Veterinary Biological Vaccines Market report are Livestock, Swine, Chicken, Others

What are the Type segmentation covered in the Veterinary Biological Vaccines Market report?

Ans: The Types covered in the Veterinary Biological Vaccines Market report are Live Attenuated Vaccines, Inactivated Vaccines, Others

Recommended Reports

Veterinary Vaccines

Animal Diagnostics

Supplement & Therapeutics

1 Veterinary Biological Vaccines Market Overview
1.1 Product Definition
1.2 Veterinary Biological Vaccines by Type
1.2.1 Global Veterinary Biological Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Veterinary Biological Vaccines by Application
1.3.1 Global Veterinary Biological Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Others
1.4 Global Veterinary Biological Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary Biological Vaccines Revenue 2020-2031
1.4.2 Global Veterinary Biological Vaccines Sales 2020-2031
1.4.3 Global Veterinary Biological Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary Biological Vaccines Market Competition by Manufacturers
2.1 Global Veterinary Biological Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Biological Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary Biological Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary Biological Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Biological Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Biological Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Biological Vaccines, Date of Enter into This Industry
2.8 Global Veterinary Biological Vaccines Market Competitive Situation and Trends
2.8.1 Global Veterinary Biological Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Biological Vaccines Players Market Share by Revenue
2.8.3 Global Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Biological Vaccines Market Scenario by Region
3.1 Global Veterinary Biological Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary Biological Vaccines Sales by Region: 2020-2031
3.2.1 Global Veterinary Biological Vaccines Sales by Region: 2020-2025
3.2.2 Global Veterinary Biological Vaccines Sales by Region: 2026-2031
3.3 Global Veterinary Biological Vaccines Revenue by Region: 2020-2031
3.3.1 Global Veterinary Biological Vaccines Revenue by Region: 2020-2025
3.3.2 Global Veterinary Biological Vaccines Revenue by Region: 2026-2031
3.4 North America Veterinary Biological Vaccines Market Facts & Figures by Country
3.4.1 North America Veterinary Biological Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary Biological Vaccines Sales by Country (2020-2031)
3.4.3 North America Veterinary Biological Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Biological Vaccines Market Facts & Figures by Country
3.5.1 Europe Veterinary Biological Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary Biological Vaccines Sales by Country (2020-2031)
3.5.3 Europe Veterinary Biological Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Biological Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Biological Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary Biological Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary Biological Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Veterinary Biological Vaccines Market Facts & Figures by Country
3.7.1 Latin America Veterinary Biological Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary Biological Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Veterinary Biological Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Biological Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Biological Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary Biological Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary Biological Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Biological Vaccines Sales by Type (2020-2031)
4.1.1 Global Veterinary Biological Vaccines Sales by Type (2020-2025)
4.1.2 Global Veterinary Biological Vaccines Sales by Type (2026-2031)
4.1.3 Global Veterinary Biological Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Biological Vaccines Revenue by Type (2020-2031)
4.2.1 Global Veterinary Biological Vaccines Revenue by Type (2020-2025)
4.2.2 Global Veterinary Biological Vaccines Revenue by Type (2026-2031)
4.2.3 Global Veterinary Biological Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary Biological Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary Biological Vaccines Sales by Application (2020-2031)
5.1.1 Global Veterinary Biological Vaccines Sales by Application (2020-2025)
5.1.2 Global Veterinary Biological Vaccines Sales by Application (2026-2031)
5.1.3 Global Veterinary Biological Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Veterinary Biological Vaccines Revenue by Application (2020-2031)
5.2.1 Global Veterinary Biological Vaccines Revenue by Application (2020-2025)
5.2.2 Global Veterinary Biological Vaccines Revenue by Application (2026-2031)
5.2.3 Global Veterinary Biological Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary Biological Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Veterinary Biological Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Company Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zoetis Veterinary Biological Vaccines Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Veterinary Biological Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Company Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Veterinary Biological Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Company Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CAHIC Veterinary Biological Vaccines Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Company Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HVRI Veterinary Biological Vaccines Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Yebio
6.7.1 Yebio Company Information
6.7.2 Yebio Description and Business Overview
6.7.3 Yebio Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Yebio Veterinary Biological Vaccines Product Portfolio
6.7.5 Yebio Recent Developments/Updates
6.8 DHN
6.8.1 DHN Company Information
6.8.2 DHN Description and Business Overview
6.8.3 DHN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DHN Veterinary Biological Vaccines Product Portfolio
6.8.5 DHN Recent Developments/Updates
6.9 WINSUN
6.9.1 WINSUN Company Information
6.9.2 WINSUN Description and Business Overview
6.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 WINSUN Veterinary Biological Vaccines Product Portfolio
6.9.5 WINSUN Recent Developments/Updates
6.10 Elanco
6.10.1 Elanco Company Information
6.10.2 Elanco Description and Business Overview
6.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Elanco Veterinary Biological Vaccines Product Portfolio
6.10.5 Elanco Recent Developments/Updates
6.11 Virbac
6.11.1 Virbac Company Information
6.11.2 Virbac Description and Business Overview
6.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Virbac Veterinary Biological Vaccines Product Portfolio
6.11.5 Virbac Recent Developments/Updates
6.12 CAVAC
6.12.1 CAVAC Company Information
6.12.2 CAVAC Description and Business Overview
6.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CAVAC Veterinary Biological Vaccines Product Portfolio
6.12.5 CAVAC Recent Developments/Updates
6.13 Kyoto Biken Laboratories
6.13.1 Kyoto Biken Laboratories Company Information
6.13.2 Kyoto Biken Laboratories Description and Business Overview
6.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Portfolio
6.13.5 Kyoto Biken Laboratories Recent Developments/Updates
6.14 FATRO
6.14.1 FATRO Company Information
6.14.2 FATRO Description and Business Overview
6.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 FATRO Veterinary Biological Vaccines Product Portfolio
6.14.5 FATRO Recent Developments/Updates
6.15 Vaksindo
6.15.1 Vaksindo Company Information
6.15.2 Vaksindo Description and Business Overview
6.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Vaksindo Veterinary Biological Vaccines Product Portfolio
6.15.5 Vaksindo Recent Developments/Updates
6.16 Bio-Labs
6.16.1 Bio-Labs Company Information
6.16.2 Bio-Labs Description and Business Overview
6.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Bio-Labs Veterinary Biological Vaccines Product Portfolio
6.16.5 Bio-Labs Recent Developments/Updates
6.17 Avimex Animal Health
6.17.1 Avimex Animal Health Company Information
6.17.2 Avimex Animal Health Description and Business Overview
6.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Avimex Animal Health Veterinary Biological Vaccines Product Portfolio
6.17.5 Avimex Animal Health Recent Developments/Updates
6.18 MEVAC
6.18.1 MEVAC Company Information
6.18.2 MEVAC Description and Business Overview
6.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.18.4 MEVAC Veterinary Biological Vaccines Product Portfolio
6.18.5 MEVAC Recent Developments/Updates
6.19 Biovac
6.19.1 Biovac Company Information
6.19.2 Biovac Description and Business Overview
6.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Biovac Veterinary Biological Vaccines Product Portfolio
6.19.5 Biovac Recent Developments/Updates
6.20 Atafen
6.20.1 Atafen Company Information
6.20.2 Atafen Description and Business Overview
6.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Atafen Veterinary Biological Vaccines Product Portfolio
6.20.5 Atafen Recent Developments/Updates
6.21 Dyntec
6.21.1 Dyntec Company Information
6.21.2 Dyntec Description and Business Overview
6.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Dyntec Veterinary Biological Vaccines Product Portfolio
6.21.5 Dyntec Recent Developments/Updates
6.22 Ringpu Biology
6.22.1 Ringpu Biology Company Information
6.22.2 Ringpu Biology Description and Business Overview
6.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Ringpu Biology Veterinary Biological Vaccines Product Portfolio
6.22.5 Ringpu Biology Recent Developments/Updates
6.23 Jinyu Bio-technology
6.23.1 Jinyu Bio-technology Company Information
6.23.2 Jinyu Bio-technology Description and Business Overview
6.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Jinyu Bio-technology Veterinary Biological Vaccines Product Portfolio
6.23.5 Jinyu Bio-technology Recent Developments/Updates
6.24 Jinhe Biotechnology
6.24.1 Jinhe Biotechnology Company Information
6.24.2 Jinhe Biotechnology Description and Business Overview
6.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Jinhe Biotechnology Veterinary Biological Vaccines Product Portfolio
6.24.5 Jinhe Biotechnology Recent Developments/Updates
6.25 China Animal Husbandry Industry
6.25.1 China Animal Husbandry Industry Company Information
6.25.2 China Animal Husbandry Industry Description and Business Overview
6.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.25.4 China Animal Husbandry Industry Veterinary Biological Vaccines Product Portfolio
6.25.5 China Animal Husbandry Industry Recent Developments/Updates
6.26 Wuhan Keqian Biology
6.26.1 Wuhan Keqian Biology Company Information
6.26.2 Wuhan Keqian Biology Description and Business Overview
6.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Wuhan Keqian Biology Veterinary Biological Vaccines Product Portfolio
6.26.5 Wuhan Keqian Biology Recent Developments/Updates
6.27 Pulike Biological Engineering
6.27.1 Pulike Biological Engineering Company Information
6.27.2 Pulike Biological Engineering Description and Business Overview
6.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Pulike Biological Engineering Veterinary Biological Vaccines Product Portfolio
6.27.5 Pulike Biological Engineering Recent Developments/Updates
6.28 Chengdu Kanghua Biological Products
6.28.1 Chengdu Kanghua Biological Products Company Information
6.28.2 Chengdu Kanghua Biological Products Description and Business Overview
6.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.28.4 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Portfolio
6.28.5 Chengdu Kanghua Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Biological Vaccines Industry Chain Analysis
7.2 Veterinary Biological Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Biological Vaccines Production Mode & Process Analysis
7.4 Veterinary Biological Vaccines Sales and Marketing
7.4.1 Veterinary Biological Vaccines Sales Channels
7.4.2 Veterinary Biological Vaccines Distributors
7.5 Veterinary Biological Vaccines Customer Analysis
8 Veterinary Biological Vaccines Market Dynamics
8.1 Veterinary Biological Vaccines Industry Trends
8.2 Veterinary Biological Vaccines Market Drivers
8.3 Veterinary Biological Vaccines Market Challenges
8.4 Veterinary Biological Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Veterinary Biological Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Veterinary Biological Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Veterinary Biological Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Veterinary Biological Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Veterinary Biological Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary Biological Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Veterinary Biological Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Veterinary Biological Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Veterinary Biological Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Biological Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Biological Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Biological Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Biological Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Biological Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Biological Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Veterinary Biological Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Veterinary Biological Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Veterinary Biological Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Veterinary Biological Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Veterinary Biological Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Veterinary Biological Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Veterinary Biological Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Veterinary Biological Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Veterinary Biological Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Veterinary Biological Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Veterinary Biological Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Veterinary Biological Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Veterinary Biological Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Veterinary Biological Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Veterinary Biological Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Veterinary Biological Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Veterinary Biological Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Veterinary Biological Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Veterinary Biological Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Veterinary Biological Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Veterinary Biological Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Veterinary Biological Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Veterinary Biological Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Veterinary Biological Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Veterinary Biological Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Veterinary Biological Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Veterinary Biological Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Veterinary Biological Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Veterinary Biological Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Veterinary Biological Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Veterinary Biological Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Veterinary Biological Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Biological Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Veterinary Biological Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Veterinary Biological Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Veterinary Biological Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Veterinary Biological Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Veterinary Biological Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Veterinary Biological Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Veterinary Biological Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Veterinary Biological Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Veterinary Biological Vaccines Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Veterinary Biological Vaccines Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Veterinary Biological Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Veterinary Biological Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Veterinary Biological Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Veterinary Biological Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Veterinary Biological Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Veterinary Biological Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Veterinary Biological Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Veterinary Biological Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Veterinary Biological Vaccines Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Veterinary Biological Vaccines Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Veterinary Biological Vaccines Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Zoetis Company Information
 Table 76. Zoetis Description and Business Overview
 Table 77. Zoetis Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Zoetis Veterinary Biological Vaccines Product
 Table 79. Zoetis Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Veterinary Biological Vaccines Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Ceva Company Information
 Table 86. Ceva Description and Business Overview
 Table 87. Ceva Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ceva Veterinary Biological Vaccines Product
 Table 89. Ceva Recent Developments/Updates
 Table 90. CAHIC Company Information
 Table 91. CAHIC Description and Business Overview
 Table 92. CAHIC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CAHIC Veterinary Biological Vaccines Product
 Table 94. CAHIC Recent Developments/Updates
 Table 95. HVRI Company Information
 Table 96. HVRI Description and Business Overview
 Table 97. HVRI Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. HVRI Veterinary Biological Vaccines Product
 Table 99. HVRI Recent Developments/Updates
 Table 100. Yebio Company Information
 Table 101. Yebio Description and Business Overview
 Table 102. Yebio Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Yebio Veterinary Biological Vaccines Product
 Table 104. Yebio Recent Developments/Updates
 Table 105. DHN Company Information
 Table 106. DHN Description and Business Overview
 Table 107. DHN Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. DHN Veterinary Biological Vaccines Product
 Table 109. DHN Recent Developments/Updates
 Table 110. WINSUN Company Information
 Table 111. WINSUN Description and Business Overview
 Table 112. WINSUN Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. WINSUN Veterinary Biological Vaccines Product
 Table 114. WINSUN Recent Developments/Updates
 Table 115. Elanco Company Information
 Table 116. Elanco Description and Business Overview
 Table 117. Elanco Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Elanco Veterinary Biological Vaccines Product
 Table 119. Elanco Recent Developments/Updates
 Table 120. Virbac Company Information
 Table 121. Virbac Description and Business Overview
 Table 122. Virbac Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Virbac Veterinary Biological Vaccines Product
 Table 124. Virbac Recent Developments/Updates
 Table 125. CAVAC Company Information
 Table 126. CAVAC Description and Business Overview
 Table 127. CAVAC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. CAVAC Veterinary Biological Vaccines Product
 Table 129. CAVAC Recent Developments/Updates
 Table 130. Kyoto Biken Laboratories Company Information
 Table 131. Kyoto Biken Laboratories Description and Business Overview
 Table 132. Kyoto Biken Laboratories Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Kyoto Biken Laboratories Veterinary Biological Vaccines Product
 Table 134. Kyoto Biken Laboratories Recent Developments/Updates
 Table 135. FATRO Company Information
 Table 136. FATRO Description and Business Overview
 Table 137. FATRO Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. FATRO Veterinary Biological Vaccines Product
 Table 139. FATRO Recent Developments/Updates
 Table 140. Vaksindo Company Information
 Table 141. Vaksindo Description and Business Overview
 Table 142. Vaksindo Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Vaksindo Veterinary Biological Vaccines Product
 Table 144. Vaksindo Recent Developments/Updates
 Table 145. Bio-Labs Company Information
 Table 146. Bio-Labs Description and Business Overview
 Table 147. Bio-Labs Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Bio-Labs Veterinary Biological Vaccines Product
 Table 149. Bio-Labs Recent Developments/Updates
 Table 150. Avimex Animal Health Company Information
 Table 151. Avimex Animal Health Description and Business Overview
 Table 152. Avimex Animal Health Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Avimex Animal Health Veterinary Biological Vaccines Product
 Table 154. Avimex Animal Health Recent Developments/Updates
 Table 155. MEVAC Company Information
 Table 156. MEVAC Description and Business Overview
 Table 157. MEVAC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. MEVAC Veterinary Biological Vaccines Product
 Table 159. MEVAC Recent Developments/Updates
 Table 160. Biovac Company Information
 Table 161. Biovac Description and Business Overview
 Table 162. Biovac Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Biovac Veterinary Biological Vaccines Product
 Table 164. Biovac Recent Developments/Updates
 Table 165. Atafen Company Information
 Table 166. Atafen Description and Business Overview
 Table 167. Atafen Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Atafen Veterinary Biological Vaccines Product
 Table 169. Atafen Recent Developments/Updates
 Table 170. Dyntec Company Information
 Table 171. Dyntec Description and Business Overview
 Table 172. Dyntec Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Dyntec Veterinary Biological Vaccines Product
 Table 174. Dyntec Recent Developments/Updates
 Table 175. Ringpu Biology Company Information
 Table 176. Ringpu Biology Description and Business Overview
 Table 177. Ringpu Biology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Ringpu Biology Veterinary Biological Vaccines Product
 Table 179. Ringpu Biology Recent Developments/Updates
 Table 180. Jinyu Bio-technology Company Information
 Table 181. Jinyu Bio-technology Description and Business Overview
 Table 182. Jinyu Bio-technology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Jinyu Bio-technology Veterinary Biological Vaccines Product
 Table 184. Jinyu Bio-technology Recent Developments/Updates
 Table 185. Jinhe Biotechnology Company Information
 Table 186. Jinhe Biotechnology Description and Business Overview
 Table 187. Jinhe Biotechnology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Jinhe Biotechnology Veterinary Biological Vaccines Product
 Table 189. Jinhe Biotechnology Recent Developments/Updates
 Table 190. China Animal Husbandry Industry Company Information
 Table 191. China Animal Husbandry Industry Description and Business Overview
 Table 192. China Animal Husbandry Industry Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 193. China Animal Husbandry Industry Veterinary Biological Vaccines Product
 Table 194. China Animal Husbandry Industry Recent Developments/Updates
 Table 195. Wuhan Keqian Biology Company Information
 Table 196. Wuhan Keqian Biology Description and Business Overview
 Table 197. Wuhan Keqian Biology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 198. Wuhan Keqian Biology Veterinary Biological Vaccines Product
 Table 199. Wuhan Keqian Biology Recent Developments/Updates
 Table 200. Pulike Biological Engineering Company Information
 Table 201. Pulike Biological Engineering Description and Business Overview
 Table 202. Pulike Biological Engineering Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 203. Pulike Biological Engineering Veterinary Biological Vaccines Product
 Table 204. Pulike Biological Engineering Recent Developments/Updates
 Table 205. Chengdu Kanghua Biological Products Company Information
 Table 206. Chengdu Kanghua Biological Products Description and Business Overview
 Table 207. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 208. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product
 Table 209. Chengdu Kanghua Biological Products Recent Developments/Updates
 Table 210. Key Raw Materials Lists
 Table 211. Raw Materials Key Suppliers Lists
 Table 212. Veterinary Biological Vaccines Distributors List
 Table 213. Veterinary Biological Vaccines Customers List
 Table 214. Veterinary Biological Vaccines Market Trends
 Table 215. Veterinary Biological Vaccines Market Drivers
 Table 216. Veterinary Biological Vaccines Market Challenges
 Table 217. Veterinary Biological Vaccines Market Restraints
 Table 218. Research Programs/Design for This Report
 Table 219. Key Data Information from Secondary Sources
 Table 220. Key Data Information from Primary Sources
 Table 221. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Biological Vaccines
 Figure 2. Global Veterinary Biological Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Veterinary Biological Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Live Attenuated Vaccines Product Picture
 Figure 5. Inactivated Vaccines Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Veterinary Biological Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Veterinary Biological Vaccines Market Share by Application: 2024 & 2031
 Figure 9. Livestock
 Figure 10. Swine
 Figure 11. Chicken
 Figure 12. Others
 Figure 13. Global Veterinary Biological Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Veterinary Biological Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Veterinary Biological Vaccines Sales (2020-2031) & (K Units)
 Figure 16. Global Veterinary Biological Vaccines Average Price (US$/Unit) & (2020-2031)
 Figure 17. Veterinary Biological Vaccines Report Years Considered
 Figure 18. Veterinary Biological Vaccines Sales Share by Manufacturers in 2024
 Figure 19. Global Veterinary Biological Vaccines Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Veterinary Biological Vaccines Players: Market Share by Revenue in Veterinary Biological Vaccines in 2024
 Figure 21. Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Veterinary Biological Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Veterinary Biological Vaccines Sales Market Share by Country (2020-2031)
 Figure 24. North America Veterinary Biological Vaccines Revenue Market Share by Country (2020-2031)
 Figure 25. United States Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Veterinary Biological Vaccines Sales Market Share by Country (2020-2031)
 Figure 28. Europe Veterinary Biological Vaccines Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Veterinary Biological Vaccines Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Veterinary Biological Vaccines Revenue Market Share by Region (2020-2031)
 Figure 36. China Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Veterinary Biological Vaccines Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Veterinary Biological Vaccines Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Veterinary Biological Vaccines Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Veterinary Biological Vaccines Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Veterinary Biological Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Veterinary Biological Vaccines by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Veterinary Biological Vaccines by Type (2020-2031)
 Figure 57. Global Veterinary Biological Vaccines Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Veterinary Biological Vaccines by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Veterinary Biological Vaccines by Application (2020-2031)
 Figure 60. Global Veterinary Biological Vaccines Price (US$/Unit) by Application (2020-2031)
 Figure 61. Veterinary Biological Vaccines Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI